Sopharma AD operates in the Drug stores and proprietary stores sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sopharma AD with three other
drug stores in Europe:
Aptechnaya set' 36,6' PAO
of RUSSIAN FEDERATION
sales of 46.05 billion Russian Rubles [US$582.98 million]
of which 100%
Farmaceutica Remedia SA
(446.41 million Romanian Leu [US$107.54 million]
Shop Apotheke Europe NV
based in GERMANY
(701.01 million Euros [US$823.75 million]
of which 88%
Sopharma AD reported sales of 1.29 billion Bulgarian Levas (US$776.68 million)
December of 2019.
increase of 8.7%
versus 2018, when the company's sales were 1.19 billion Bulgarian Levas.
This was the third consecutive year of growth at Sopharma AD.
Sales of Production of Pharmaceutical Products saw an increase
9.2% in 2019, from
231.92 million Bulgarian Levas to 253.16 million Bulgarian Levas.